As of Sep 03
| -3.79 / -2.47%|
The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 175.00, with a high estimate of 244.00 and a low estimate of 92.00. The median estimate represents a +16.70% increase from the last price of 149.96.
The current consensus among 14 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.